Search

Displaying results 5231 - 5240 of 7018 in total
  1. Drug

    Atinumab

    go.drugbank.com/drugs/DB17923
    Investigational

    ATI-355 is a humanized anti-Nogo-A antibody developed by Novartis.

  2. Drug

    Sonesitatug Vedotin

    go.drugbank.com/drugs/DB18619
    Investigational

    CMG901 is an anti-Claudin 18.2 monoclonal antibody conjugated with MMAE payload.

    Synonyms: an anti-Claudin 18.2 monoclonal antibody conjugated with MMAE payload
  3. Drug

    Zotarolimus

    go.drugbank.com/drugs/DB18761
    Investigational

    Zotarolimus is an immunosuppressant under investigation for use in drug-eluting stents.

  4. Drug

    KT-333

    go.drugbank.com/drugs/DB17165
    Investigational

    KT-333 is a small molecule targeted protein degrader of STAT3.[L44086]

  5. Drug

    APT3111

    go.drugbank.com/drugs/DB06390
    Experimental

    APT3111 is an investigational drug used to treat PNH (paroxysmal nocturnal haemoglobinurea).

    Synonyms: APT 2392
  6. Drug

    Trodusquemine

    go.drugbank.com/drugs/DB06333
    Investigational

    Trodusquemine, a spermine metabolite of cholesterol, is a naturally occurring aminosterol that inhibits protein tyrosine phosphatase 1B. … It has demonstrated the ability to stimulate regeneration of heart and multiple other tissues in animal models [A176600].

  7. Drug

    Olesoxime

    go.drugbank.com/drugs/DB05185
    Investigational

    Olesoxime is a cholesterol-like small molecule that has demonstrated a remarkable neuroprotective profile in a battery of both in vitro and in vivo preclinical models. … For example, it has demonstrated the ability to prevent neurodegeneration, enhance nerve function and accelerate neuroregeneration following nerve trauma.[A3282,A253233]

  8. Drug

    Fluprednidene acetate

    go.drugbank.com/drugs/DB14634
    Investigational

    Fluprednidene acetate is a corticosteroid. It has anti-inflammatory and anti-allergic properties.

  9. Drug

    NKX101

    go.drugbank.com/drugs/DB18131
    Investigational

    NKX101 is an investigational allogeneic chimeric antigen receptor (CAR)-natural killer cell therapy.

    Synonyms: a fourth generation activating chimeric receptor (ACR) natural killer (NK) cell therapy engineered with an NKG2D ACR, OX40 costimulatory domain, CD3zeta signaling moiety, and membrane bound IL-15 (mb-IL15
  10. Drug

    Mepindolol

    go.drugbank.com/drugs/DB13530
    Investigational

    Mepindolol is a 2-methyl derivative of pindolol. It is a beta blocker.